Mountcastle David 4
4 · Privia Health Group, Inc. · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Mountcastle David
EVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock, par value $0.01 per share
2025-12-12$2.00/sh+23,887$47,774→ 196,796 total - Sale
Common Stock, par value $0.01 per share
2025-12-12$25.03/sh−23,887$597,892→ 172,909 total - Exercise/Conversion
Stock Option (Right to Purchase)
2025-12-12−7,698→ 17,820 totalExercise: $2.00Exp: 2028-08-27→ Common Stock, par value $0.01 per share (7,698 underlying) - Exercise/Conversion
Stock Option (Right to Purchase)
2025-12-12−4,792→ 12,452 totalExercise: $2.00Exp: 2029-03-20→ Common Stock, par value $0.01 per share (4,792 underlying) - Exercise/Conversion
Stock Option (Right to Purchase)
2025-12-12−3,430→ 5,501 totalExercise: $2.00Exp: 2029-12-03→ Common Stock, par value $0.01 per share (3,430 underlying) - Exercise/Conversion
Stock Option (Right to Purchase)
2025-12-12−7,967→ 2,866 totalExercise: $2.00Exp: 2030-09-07→ Common Stock, par value $0.01 per share (7,967 underlying)
Holdings
- 8,695(indirect: By Spouse)
Common Stock, $0.01 par value per share
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.16 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]All of the stock options are fully vested and exercisable.